Pentixapharm Holding AG
PTP | F
Overview
Corporate Details
- ISIN(s):
- DE000A383RV0 (+1 more)
- LEI:
- 3912005VBOVXNDXEQZ36
- Country:
- Germany
- Address:
- Robert-Rössle-Straße, 10, 13125 Berlin
- Website:
- https://www.pentixapharm.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Pentixapharm is a clinical-stage radiopharmaceutical development company founded in 2019 with its offices in Berlin and W�rzburg, Germany. It is committed to developing CXCR4 ligand-based first-in-class radiopharmaceutical approaches for diagnostic and therapeutic programs in a number of hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases. The specific binding of the ligand to the pathological surface structure of the target cell is identical for both diagnosis and therapy, enabling a theranostic mode of action.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-27 09:43 |
Inside Information Statement
Pentixapharm Holding AG: Pentixapharm outlines new clinical development strategy
|
English | 10.0 KB | |
| 2025-05-08 00:00 |
Regulatory News Service
Q1 statement / Q1 financial report 2025
|
English | 479.2 KB | |
| 2025-04-26 16:00 |
Report Publication Announcement
|
English | 3.8 KB | |
| 2025-04-25 00:00 |
Regulatory News Service
Annual financial report 2024
|
English | 2.3 MB | |
| 2025-04-24 14:00 |
Regulatory News Service
Pentixapharm Signs Contract Manufacturing Agreement for Yttrium-90-based Pentix…
|
English | 8.8 KB | |
| 2025-04-17 15:05 |
Regulatory News Service
Pentixapharm Holding AG: Bekanntmachung der Einberufung zur Hauptversammlung am…
|
German | 88.5 KB | |
| 2025-04-15 08:17 |
Regulatory News Service
Pentixapharm Holding AG Releases Financial Results for 2024 and Announces Guida…
|
English | 6.4 KB | |
| 2025-03-19 13:20 |
Regulatory News Service
|
English | 3.9 KB | |
| 2025-03-18 13:20 |
Regulatory News Service
|
English | 3.9 KB | |
| 2025-03-04 14:38 |
Board/Management Change
Changes in the Supervisory Board and Management Board of Pentixapharm Holding AG
|
English | 6.4 KB | |
| 2025-03-03 14:38 |
Board/Management Change
Changes in the Supervisory Board and Management Board of Pentixapharm Holding AG
|
English | 6.4 KB | |
| 2025-02-14 14:10 |
Regulatory News Service
First-In-Human Data about the Treatment of Muscle-Invasive Bladder Cancer with …
|
English | 7.5 KB | |
| 2025-02-13 14:10 |
Regulatory News Service
First-In-Human Data about the Treatment of Muscle-Invasive Bladder Cancer with …
|
English | 7.5 KB | |
| 2025-01-25 17:00 |
Earnings Release
Pentixapharm Holding AG Closes the 2024 Financial Year With a Loss of EUR 14 Mi…
|
English | 6.3 KB | |
| 2025-01-24 17:00 |
Earnings Release
Pentixapharm Holding AG Closes the 2024 Financial Year With a Loss of EUR 14 Mi…
|
English | 6.3 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
GenSight Biologics S.A. | France | SIGHT | |
|
Gentian Diagnostics ASA | Norway | GENT | |
|
Genus PLC | United Kingdom | GNS | |
|
Grace Breeding Ltd. | Israel | GRAC | |
|
Group 107 Ltd. | Israel | G107 | |
|
Guard Therapeutics International AB | Sweden | GUARD | |
|
Gubra A/S | Denmark | GUBRA | |
|
Hadasit Bio Holding Ltd. | Israel | HDST-M | |
|
Hansa Biopharma | Sweden | HNSA | |
|
HEMOGENYX PHARMACEUTICALS PLC | United Kingdom | HEMO |